- Dabigo 75 mg Capsule effectively prevents blood clots, reducing the risk of stroke.
- This formulation is beneficial for patients with deep vein thrombosis.
- Dabigo 75 mg Capsule aids in preventing pulmonary embolism.
- It is used to lower the risk of heart attacks associated with clot formation.
- Dabigo 75 mg Capsule supports patients undergoing certain surgical procedures by minimizing clot risks.
- This medication is advantageous for individuals with atrial fibrillation.
- Dabigo 75 mg Capsule helps maintain proper blood flow and circulation.
- It is effective in managing anticoagulation therapy without frequent lab tests.
Dabigo 75 mg Capsule - Strip of 10
Compositions : Dabigatran 75mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Sun Pharmaceutical Industries Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Dabigo 75 mg Capsule is a specialized medication designed to prevent the formation of blood clots in the body. This formulation contains the active ingredient Dabigatran Etexilate, which is classified as a novel oral anticoagulant (NOAC). The primary purpose of Dabigo 75 mg Capsule is to reduce the risk of stroke and other serious conditions associated with blood clots, such as deep vein thrombosis and pulmonary embolism. By inhibiting specific clotting factors in the blood, Dabigo 75 mg Capsule plays a crucial role in maintaining cardiovascular health. Patients prescribed Dabigo 75 mg Capsule can benefit from its effectiveness in managing and preventing thromboembolic events. The composition of Dabigo 75 mg Capsule ensures that it is both potent and safe for use under medical supervision. As a part of its therapeutic category, Dabigo 75 mg Capsule is essential for individuals at risk of developing blood clots due to various medical conditions or surgical procedures. Understanding the importance of Dabigo 75 mg Capsule in treatment regimens can empower patients to adhere to their prescribed therapies effectively. Overall, Dabigo 75 mg Capsule represents a significant advancement in anticoagulation therapy, providing patients with a reliable option for managing their health.
Product Details
Dabigo 75 mg Capsule works by inhibiting thrombin, a key enzyme in the blood coagulation process. This action prevents the formation of fibrin, which is essential for blood clot development.
- Dabigo 75 mg Capsule reduces the ability of blood to clot, thereby preventing thrombus formation.
- This medication provides rapid anticoagulation effects after administration.
- Dabigo 75 mg Capsule does not require routine monitoring like traditional anticoagulants.
- It offers a predictable pharmacokinetic profile, allowing for consistent dosing.
- The formulation enhances patient compliance due to its ease of use.
- Dabigo 75 mg Capsule should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one capsule taken twice daily.
- It is advisable to take Dabigo 75 mg Capsule at the same time each day for optimal results.
- This medication can be taken with or without food, but consistency is key.
- Patients should not stop taking Dabigo 75 mg Capsule without consulting their doctor.
- Duration of treatment may vary based on individual health conditions and should be determined by a healthcare provider.
- Special instructions may include avoiding activities that increase bleeding risk while on Dabigo 75 mg Capsule.
- Maintain a balanced diet rich in fruits and vegetables while taking Dabigo 75 mg Capsule.
- Avoid excessive alcohol consumption to minimize bleeding risks associated with this medication.
- Engage in regular physical activity to support overall cardiovascular health.
- Stay hydrated to help maintain optimal kidney function during treatment with Dabigo 75 mg Capsule.
- Avoid activities that could lead to injury or bleeding while on this medication.
Safety Advice
Side Effects
- Common side effects of Dabigo 75 mg Capsule include nausea and gastrointestinal discomfort.
- Some patients may experience dyspepsia or abdominal pain while taking this medication.
- Skin bleeding and nosebleeds are potential side effects that should be monitored.
- Serious side effects may include signs of bleeding such as blood in urine or stool.
- If any severe side effects occur, immediate medical attention should be sought.
- Consultation with a healthcare provider is essential if side effects persist or worsen.
Precautions and Warnings
- Dabigo 75 mg Capsule should not be used by individuals with active bleeding disorders.
- Patients with severe kidney impairment must avoid using this medication.
- Pregnant or breastfeeding women should consult their doctor before using Dabigo 75 mg Capsule.
- Alcohol consumption may increase bleeding risk while on this medication.
- Driving or operating heavy machinery should be approached with caution due to potential dizziness.
- Regular monitoring of kidney function may be required during treatment with Dabigo 75 mg Capsule.
FAQs
Dabigo 75 mg Capsule is primarily used for preventing blood clots that can lead to serious conditions like stroke and deep vein thrombosis.
2. How should I take Dabigo 75 mg Capsule?
Dabigo 75 mg Capsule should be taken as prescribed by your healthcare provider, usually one capsule twice daily.
3. Are there any side effects associated with Dabigo 75 mg Capsule?
Common side effects include nausea and gastrointestinal discomfort.
Serious side effects may involve unusual bleeding.
4. Can I drink alcohol while taking Dabigo 75 mg Capsule?
It is advisable to limit alcohol intake while using Dabigo 75 mg Capsule due to increased bleeding risks.
5. Who should avoid using Dabigo 75 mg Capsule?
Individuals with active bleeding disorders or severe kidney impairment should not use Dabigo 75 mg Capsule.
6. What should I do if I miss a dose of Dabigo 75 mg Capsule?
If you miss a dose of Dabigo 75 mg Capsule, take it as soon as you remember unless it's almost time for your next dose.
7. Is regular monitoring required while taking Dabigo 75 mg Capsule?
Unlike some anticoagulants, regular lab tests are not typically required when using Dabigo 75 mg Capsule.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 107906 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Sun Pharmaceutical Industries Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Dabigo 75 mg Capsule is a specialized medication designed to prevent the formation of blood clots in the body. This formulation contains the active ingredient Dabigatran Etexilate, which is classified as a novel oral anticoagulant (NOAC). The primary purpose of Dabigo 75 mg Capsule is to reduce the risk of stroke and other serious conditions associated with blood clots, such as deep vein thrombosis and pulmonary embolism. By inhibiting specific clotting factors in the blood, Dabigo 75 mg Capsule plays a crucial role in maintaining cardiovascular health. Patients prescribed Dabigo 75 mg Capsule can benefit from its effectiveness in managing and preventing thromboembolic events. The composition of Dabigo 75 mg Capsule ensures that it is both potent and safe for use under medical supervision. As a part of its therapeutic category, Dabigo 75 mg Capsule is essential for individuals at risk of developing blood clots due to various medical conditions or surgical procedures. Understanding the importance of Dabigo 75 mg Capsule in treatment regimens can empower patients to adhere to their prescribed therapies effectively. Overall, Dabigo 75 mg Capsule represents a significant advancement in anticoagulation therapy, providing patients with a reliable option for managing their health.
- Dabigo 75 mg Capsule effectively prevents blood clots, reducing the risk of stroke.
- This formulation is beneficial for patients with deep vein thrombosis.
- Dabigo 75 mg Capsule aids in preventing pulmonary embolism.
- It is used to lower the risk of heart attacks associated with clot formation.
- Dabigo 75 mg Capsule supports patients undergoing certain surgical procedures by minimizing clot risks.
- This medication is advantageous for individuals with atrial fibrillation.
- Dabigo 75 mg Capsule helps maintain proper blood flow and circulation.
- It is effective in managing anticoagulation therapy without frequent lab tests.
Dabigo 75 mg Capsule works by inhibiting thrombin, a key enzyme in the blood coagulation process. This action prevents the formation of fibrin, which is essential for blood clot development.
- Dabigo 75 mg Capsule reduces the ability of blood to clot, thereby preventing thrombus formation.
- This medication provides rapid anticoagulation effects after administration.
- Dabigo 75 mg Capsule does not require routine monitoring like traditional anticoagulants.
- It offers a predictable pharmacokinetic profile, allowing for consistent dosing.
- The formulation enhances patient compliance due to its ease of use.
- Dabigo 75 mg Capsule should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one capsule taken twice daily.
- It is advisable to take Dabigo 75 mg Capsule at the same time each day for optimal results.
- This medication can be taken with or without food, but consistency is key.
- Patients should not stop taking Dabigo 75 mg Capsule without consulting their doctor.
- Duration of treatment may vary based on individual health conditions and should be determined by a healthcare provider.
- Special instructions may include avoiding activities that increase bleeding risk while on Dabigo 75 mg Capsule.
- Maintain a balanced diet rich in fruits and vegetables while taking Dabigo 75 mg Capsule.
- Avoid excessive alcohol consumption to minimize bleeding risks associated with this medication.
- Engage in regular physical activity to support overall cardiovascular health.
- Stay hydrated to help maintain optimal kidney function during treatment with Dabigo 75 mg Capsule.
- Avoid activities that could lead to injury or bleeding while on this medication.
Side Effects
- Common side effects of Dabigo 75 mg Capsule include nausea and gastrointestinal discomfort.
- Some patients may experience dyspepsia or abdominal pain while taking this medication.
- Skin bleeding and nosebleeds are potential side effects that should be monitored.
- Serious side effects may include signs of bleeding such as blood in urine or stool.
- If any severe side effects occur, immediate medical attention should be sought.
- Consultation with a healthcare provider is essential if side effects persist or worsen.
Precautions and Warnings
- Dabigo 75 mg Capsule should not be used by individuals with active bleeding disorders.
- Patients with severe kidney impairment must avoid using this medication.
- Pregnant or breastfeeding women should consult their doctor before using Dabigo 75 mg Capsule.
- Alcohol consumption may increase bleeding risk while on this medication.
- Driving or operating heavy machinery should be approached with caution due to potential dizziness.
- Regular monitoring of kidney function may be required during treatment with Dabigo 75 mg Capsule.
Dabigo 75 mg Capsule is primarily used for preventing blood clots that can lead to serious conditions like stroke and deep vein thrombosis.
2. How should I take Dabigo 75 mg Capsule?
Dabigo 75 mg Capsule should be taken as prescribed by your healthcare provider, usually one capsule twice daily.
3. Are there any side effects associated with Dabigo 75 mg Capsule?
Common side effects include nausea and gastrointestinal discomfort.
Serious side effects may involve unusual bleeding.
4. Can I drink alcohol while taking Dabigo 75 mg Capsule?
It is advisable to limit alcohol intake while using Dabigo 75 mg Capsule due to increased bleeding risks.
5. Who should avoid using Dabigo 75 mg Capsule?
Individuals with active bleeding disorders or severe kidney impairment should not use Dabigo 75 mg Capsule.
6. What should I do if I miss a dose of Dabigo 75 mg Capsule?
If you miss a dose of Dabigo 75 mg Capsule, take it as soon as you remember unless it's almost time for your next dose.
7. Is regular monitoring required while taking Dabigo 75 mg Capsule?
Unlike some anticoagulants, regular lab tests are not typically required when using Dabigo 75 mg Capsule.
Directions for Use
Storage and Disposal
| SKU | 107906 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Sun Pharmaceutical Industries Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account